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Introduction: Testicular tumors are a heterogeneous group of neoplasms exhibiting diverse histopathology and can
be classified as seminomatous and non-seminomatous germ cell tumor types. Mixed germ cell tumors contain more
than one germ cell component and various combinations have been reported. Here, we present a rare case of a mixed
germ cell tumor composed of seminoma, choriocarcinoma and teratoma with a secondary somatic malignancy.
Case presentation: A 31-year-old Caucasian man presented with splenic rupture to our hospital. A right-sided
testicular swelling had been present for 6 months and his alpha-fetoprotein, beta-human chorionic gonadotropin,
and lactose dehydrogenase were increased. An ultrasound of his scrotum revealed an enlarged right testis with
heterogeneous echogenicity. Multiple hypervascular lesions were noted in his liver and spleen. He underwent
transcatheter embolization therapy of his splenic artery followed by splenectomy and right-sided orchiectomy.
A computed tomography scan also showed metastasis to both lungs. During his last follow up after four cycles
of cisplatin-based chemotherapy, the level of tumor markers had decreased, decreases in the size of his liver
and pulmonary lesions were noted but new sclerotic lesions were evident in his thoracolumbar region raising
concern for bony metastasis.
Conclusions: Prognosis of testicular tumor depends mainly on the clinical stage, but emergence of a
sarcomatous component presents a challenge in the treatment of germ cell tumors and the histological
subtype of this component can be used as a guide to specific chemotherapy in these patients.
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Testicular tumors are a heterogeneous group of neo-
plasms exhibiting diverse histopathology, variable clin-
ical course and prognosis [1]. Of these tumors, 30 to
50% are classified as mixed germ cell tumors (GCT) [2]
and several studies have assessed the frequency of vari-
ous histological elements seen in these tumors [3,4]. The
combination of seminoma and choriocarcinoma is re-
ported to be extremely rare. Further, the presence of a
sarcomatous component (SC) in a GCT is an infrequent
phenomenon with great implications on clinical out-
come and prognosis [5]. We report a rare case of mixed
GCT with combination of seminoma, choriocarcinoma* Correspondence: Amandeep.Aneja@tuhs.temple.edu
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rhabdomyosarcoma.
Case presentation
A 31-year-old Caucasian man was referred to our hospital
for splenic rupture with active arterial extravasation. During
clinical evaluation, he mentioned right testicular swelling;
the swelling had been enlarging for 6 months. Transcatheter
embolization therapy of the inferior pole of his splenic artery
was performed for what was clinically thought to be a
hypervascular metastasis in the spleen. Multiple hypervascu-
lar lesions were also noted in his liver. An ultrasound of his
scrotum revealed an enlarged right testis with heterogeneous
echogenicity measuring 5×4×3cm. Serum tumor markers
revealed a beta-human chorionic gonadotropin (hCG) of
3804mIU/mL (<5mIU/mL), lactose dehydrogenase (LDH)
of 196U/L (100 to 190U/L) and an alpha-fetoprotein (AFP)td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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orchiectomy and splenectomy. No lymph node dissection
was performed.
On gross pathological examination, a 5.1×5×2.5cm
heterogeneous testicular mass, exhibiting tan-white to yel-
low to hemorrhagic areas was evident. No gross involve-
ment of his tunica albuginea or spermatic cord was noted.
Histopathology showed a mixed GCT, confined to the
testis containing seminoma, classic type (40%; Figure 1A),
teratoma (40%; Figure 1B) with a secondary somatic ma-
lignancy (rhabdomyosarcoma; Figure 1C) and choriocar-
cinoma (20%; Figure 1D). The SC consisted of striated
muscle cells with hyperchromatic bizarre nuclei and mi-
totic figures (Figure 2). Lymphovascular invasion and ex-
tension into the rete testis was observed. The epididymis
was free of tumor. Intratubular germ cell neoplasia was
also identified.
Immunohistochemistry stains displayed strong staining
with placental alkaline phosphatase (Figure 3A) and c-kit
(Figure 3B) in the seminomatous component. Epithelial
membrane antigen (Figure 3C) and cytokeratin positivity
were observed in the glandular component of the tera-
toma. The rhabdomyosarcoma showed positivity with
vimentin and the choriocarcinoma was positive for inhibin
(Figure 3D), cytokeratin and beta-hCG. Gross examination
of his spleen showed four discrete foci suspicious for
metastatic disease but microscopic examination revealedFigure 1 Histological features of mixed germ cell tumor and sarcoma
fibrous septa, seminoma. Hematoxylin and eosin, 10×. (B) Keratinizing squa
muscle cells with bizzare hyperchromatic nuclei, rhabdomyosarcoma. Hem
(cytotrophoblasts) and multinucleated cells (syncytiotrophoblasts) in a hemnecrotic tissue without evidence of metastasis. Final
pathological staging was pT2pNxpM0. However, com-
puted tomography of his abdomen was suggestive of
metastasis to his liver and both lungs making his diag-
nosis clinical stage IIIC.
He was placed on cisplatin-based chemotherapy and he
has received four rounds to date. Bleomycin was omitted
from the first round only because he was unable to per-
form pulmonary function tests; his exhalation time was too
short and the end test criteria were not met. A repeat pul-
monary function test 2 weeks later revealed normal air
flow and normal diffusion capacity. By the end of the
fourth cycle, his AFP had returned to normal and his beta-
hCG had decreased to 137mIU/mL and LDH was 196U/L.
During his last follow up, we observed that his pul-
monary and liver lesions had decreased in size but new
sclerotic lesions had developed in his thoracolumbar
spine which raised concerns of bony metastatic involve-
ment. A biopsy of his L5 vertebral body however, showed
no evidence of metastatic disease.
Discussion
Several studies have reported specific combinations of
different GCT elements in mixed GCT of testis [2,3].
Mostofi [3] in classifying more than 6000 testicular tu-
mors found >1 histological patterns in approximately
60% of cases with the most frequent combination oftous component. (A) Compact nests of tumor cells separated by
mous epithelium, teratoma, hematoxylin and eosin, 4×. (C) Striated
atoxylin and eosin, 20×. (D) Admixture of polygonal cells
orrhagic background, choriocarcinoma. Hematoxylin and eosin, 10×.
Figure 2 Striated muscle cells, rhabdomyosarcoma. Hematoxylin
and eosin, 40×.
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oma. Statistical analysis of possible combinations by
Mosharafa et al. revealed 10 possible pair combinations
with the strongest correlation between teratoma and
yolk sac tumor [6]. To the best of our knowledge, the
combination of seminoma, choriocarcinoma and tera-
toma with rhabdomyosarcoma as a secondary somatic
malignancy has not been reported so far.
According to the World Health Organization, a tera-
toma with somatic malignancy can be defined as aFigure 3 Immunohistochemical stains. (A) Seminoma, positive staining f
for c-Kit, 20×. (C) Teratoma, positive staining for epithelial membrane antigteratoma containing a malignant component of a type
typically encountered in other organs and tissues, for ex-
ample sarcomas and carcinomas [7]. Absence of this
combination of germ cell elements in separate studies by
Malagón et al. and Guo et al. of 46 and 33 cases respect-
ively of GCT with a SC further support this as a rare
combination of germ cell elements exhibiting a SC [5,8].
There are several hypotheses regarding the origin of
SC in GCT. As this component tends to occur in GCTs
that contain a teratomatous component, it has been sug-
gested that SC may arise from malignant transformation
of teratomatous mesenchyme. However, reports of SC in
GCT without teratomatous component point towards
other mechanisms such as aberrant differentiation of
primitive germ cells and de-differentiation of blastoma-
tous stroma in yolk sac component [5,9].
The majority of the sarcomatous tumor of the testis is
an element of germ cell neoplasia but, occasionally, can
be seen as an invasion from a paratesticular sarcoma or
as a primary intratesticular sarcoma. However, this is a
rare occurrence. Stewart et al. found only six cases, of
which four were paratesticular and two were testicular,
in a 30-year review of intrascrotal rhabdomyosarcomas
[10]. Erbay et al. while reporting a case of primary tes-
ticular rhabdomyosarcoma emphasized investigating for
the teratomatous elements in the primary tumor due to
the rarity of this entity [11]. They also advised serial
serologic evaluation of beta-hCG and AFP to excludeor placental alkaline phosphatase, 20×. (B) Seminoma, positive staining
en, 10×. (D) Choriocarcinoma, positive staining for inhibin, 10×.
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ant to differentiate SC from focal atypical stromal prolif-
erations commonly seen in teratoma [8]. These areas
usually lack marked cytological atypia and do not form
an expansile nodule whereas the sarcomatous cells show
prominent cytologic atypia, brisk mitotic activity and
complex growth pattern. The histological analysis in our
case clearly showed latter areas present within the tera-
tomatous component.
Development of SC presents a challenge in the treat-
ment of testicular GCT. Malagón et al. reported a statis-
tically significant difference in survival (P<0.001) for
patients having a SC in their GCT when compared to
age and stage-matched patients with GCTs without SC
[5]. Many studies have revealed resistance to the cisplatin-
based chemotherapy in GCTs with SC [12-15]. Donadio
et al. emphasized in their study the importance of histo-
logical type of SC as a guide to specific chemotherapy in
their patients, for example GCT with rhabdomyosarcoma
responds well to a doxorubicin-based regimen whereas
GCTs with secondary adenocarcinoma benefit from
5-fluorouracil-based chemotherapy [16]. Guo et al.
suggested in their study that the SC confined to the
primary testicular GCT may not have as high a risk of
mortality as those at a comparable stage without a SC
[8]. They further indicated that patients with SC in
metastasis may benefit from sarcomatous-oriented
drugs. Alternatively, SC may occur in primary testicu-
lar GCT or metastasis.
Conclusions
We report the first known example of a GCT with an un-
usual combination of seminoma, choriocarcinoma and
teratoma with a somatic malignancy. This case not only
reflects the heterogeneity in the biology of GCT of the
testis but also highlights the aggressiveness of these tu-
mors and challenges in treatment due to the emer-
gence of a SC in them.
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